It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...

We run the ruler over ASX health stock quarterlies, with Bioxyne achieving record Q2 FY25 trading revenue. ... Read More The post ASX Quarterly Health Wrap: Bioxyne revenue up 77%, Radiopharm lists on ...

President Ursula von der Leyen presented the European Commission's plan to boost Europe's competitiveness and turn it into a place where future ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...